190 related articles for article (PubMed ID: 27910913)
21. Trophoblast subtype-specific EGFR/ERBB4 expression correlates with cell cycle progression and hyperplasia in complete hydatidiform moles.
Fock V; Plessl K; Fuchs R; Dekan S; Milla SK; Haider S; Fiala C; Knöfler M; Pollheimer J
Hum Reprod; 2015 Apr; 30(4):789-99. PubMed ID: 25740878
[TBL] [Abstract][Full Text] [Related]
22. A study of therapy for pediatric hepatoblastoma: prevention and treatment of pulmonary metastasis.
Uchiyama M; Iwafuchi M; Naito M; Yagi M; Iinuma Y; Kanada S; Tsukada K
Eur J Pediatr Surg; 1999 Jun; 9(3):142-5. PubMed ID: 10427488
[TBL] [Abstract][Full Text] [Related]
23. Pediatric patient with end-stage kidney disease secondary to Eagle-Barrett syndrome and metastatic unresectable hepatoblastoma treated successfully with chemotherapy and liver-kidney transplant.
Ortiz D; Harden A; Corrales-Medina FF; Saigal G; Tekin A; Garcia J
Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29356335
[TBL] [Abstract][Full Text] [Related]
24. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
25. A kinome siRNA screen identifies HGS as a potential target for liver cancers with oncogenic mutations in CTNNB1.
Canal F; Anthony E; Lescure A; Del Nery E; Camonis J; Perez F; Ragazzon B; Perret C
BMC Cancer; 2015 Dec; 15():1020. PubMed ID: 26715116
[TBL] [Abstract][Full Text] [Related]
26. Relationship of β-catenin and postchemotherapy histopathologic changes with overall survival in patients with hepatoblastoma.
Gupta K; Rane S; Das A; Marwaha RK; Menon P; Rao KL
J Pediatr Hematol Oncol; 2012 Nov; 34(8):e320-8. PubMed ID: 22735888
[TBL] [Abstract][Full Text] [Related]
27. Expression of epidermal growth factor (EGF), its receptor, and related oncoprotein (erbB-2) in human pituitary tumors and response to EGF in vitro.
Chaidarun SS; Eggo MC; Sheppard MC; Stewart PM
Endocrinology; 1994 Nov; 135(5):2012-21. PubMed ID: 7956924
[TBL] [Abstract][Full Text] [Related]
28. [Current status of diagnosis and treatment of hepatoblastoma].
García-Miguel P; López Santamaría M
Clin Transl Oncol; 2005 Aug; 7(7):328-34. PubMed ID: 16185597
[No Abstract] [Full Text] [Related]
29. Targeting the Neurokinin-1 Receptor Compromises Canonical Wnt Signaling in Hepatoblastoma.
Ilmer M; Garnier A; Vykoukal J; Alt E; von Schweinitz D; Kappler R; Berger M
Mol Cancer Ther; 2015 Dec; 14(12):2712-21. PubMed ID: 26516161
[TBL] [Abstract][Full Text] [Related]
30. Surgery for hepatoblastoma: from laparoscopic resection to liver transplantation.
Kim T; Kim DY; Cho MJ; Kim SC; Seo JJ; Kim IK
Hepatogastroenterology; 2011; 58(107-108):896-9. PubMed ID: 21830412
[TBL] [Abstract][Full Text] [Related]
31. Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma.
Meyers RL; Katzenstein HM; Krailo M; McGahren ED; Malogolowkin MH
J Pediatr Surg; 2007 Dec; 42(12):2050-6. PubMed ID: 18082706
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of aminopeptidase-N (CD13) in hepatoblastoma.
Saida S; Watanabe K; Kato I; Fujino H; Umeda K; Okamoto S; Uemoto S; Hishiki T; Yoshida H; Tanaka S; Adachi S; Niwa A; Nakahata T; Heike T
Pediatr Int; 2015 Aug; 57(4):558-66. PubMed ID: 25682862
[TBL] [Abstract][Full Text] [Related]
33. Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma.
Wu JF; Chang HH; Lu MY; Jou ST; Chang KC; Ni YH; Chang MH
J Biomed Sci; 2017 Aug; 24(1):62. PubMed ID: 28851352
[TBL] [Abstract][Full Text] [Related]
34. β-Catenin mutations in 2 nested stromal epithelial tumors of the liver--a neoplasia with defective mesenchymal-epithelial transition.
Assmann G; Kappler R; Zeindl-Eberhart E; Schmid I; Häberle B; Graeb C; Jung A; Müller-Höcker J
Hum Pathol; 2012 Nov; 43(11):1815-27. PubMed ID: 22749188
[TBL] [Abstract][Full Text] [Related]
35. Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex.
Jia D; Dong R; Jing Y; Xu D; Wang Q; Chen L; Li Q; Huang Y; Zhang Y; Zhang Z; Liu L; Zheng S; Xia Q; Wang H; Dong K; He X
Hepatology; 2014 Nov; 60(5):1686-96. PubMed ID: 24912477
[TBL] [Abstract][Full Text] [Related]
36. EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patients.
Tzeng CW; Frolov A; Frolova N; Jhala NC; Howard JH; Vickers SM; Buchsbaum DJ; Heslin MJ; Arnoletti JP
J Surg Res; 2007 Nov; 143(1):20-6. PubMed ID: 17950068
[TBL] [Abstract][Full Text] [Related]
37. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.
Sette G; Salvati V; Mottolese M; Visca P; Gallo E; Fecchi K; Pilozzi E; Duranti E; Policicchio E; Tartaglia M; Milella M; De Maria R; Eramo A
Cell Death Dis; 2015 Aug; 6(8):e1850. PubMed ID: 26247735
[TBL] [Abstract][Full Text] [Related]
38. Hepatoblastoma modeling in mice places Nrf2 within a cancer field established by mutant
Comerford SA; Hinnant EA; Chen Y; Bansal H; Klapproth S; Rakheja D; Finegold MJ; Lopez-Terrada D; O'Donnell KA; Tomlinson GE; Hammer RE
JCI Insight; 2016 Oct; 1(16):e88549. PubMed ID: 27734029
[TBL] [Abstract][Full Text] [Related]
39. High tricellulin expression is associated with better survival in human hepatoblastoma.
Schlachter K; Gyugos M; Halász J; Lendvai G; Baghy K; Garami M; Gyöngyösi B; Schaff Z; Kiss A
Histopathology; 2014 Nov; 65(5):631-41. PubMed ID: 24735023
[TBL] [Abstract][Full Text] [Related]
40. Differential Expression Patterns of EGF, EGFR, and ERBB4 in Nasal Polyp Epithelium.
Duan C; Li CW; Zhao L; Subramaniam S; Yu XM; Li YY; Chen de H; Li TY; Shen L; Shi L; Wang de Y
PLoS One; 2016; 11(6):e0156949. PubMed ID: 27285994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
